Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND2 pseudogene 19 (MTND2P19) is a nuclear pseudogene similar to the mitochondrial gene MT-ND2, which encodes the NADH dehydrogenase subunit 2 of Complex I in the respiratory electron transport chain. As a pseudogene, MTND2P19 is not translated into a functional protein and is not currently recognized as a direct drug target, therapeutic receptor, or enzyme. There are no well-established biological functions, disease roles, clinical utilities, or interacting drugs associated with this pseudogene. In current research, some mitochondrial pseudogenes—including other MT-ND2 pseudogenes—have been analyzed in the context of differential expression in neurodegenerative diseases, but MTND2P19 specifically is not characterized in the biomedical literature[5]. Summary: MT-ND2 pseudogene 19 (MTND2P19) is a nuclear pseudogene and not a protein-coding gene or receptor. It is not a therapeutic target, has no established biological function, mechanism, or disease relevance, and may be incorrectly listed as a target. If you are looking for functionally relevant mitochondrial targets, consider the canonical MT-ND2 gene, which encodes the NADH dehydrogenase subunit 2, a core part of mitochondrial Complex I[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND2 pseudogene 19 (MTND2P19).